Marco De Giorgi Selected Research

Marco De Giorgi Research Topics

4	Atherosclerosis 01/2022 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 01/2019
2	Triple Negative Breast Neoplasms 01/2022 - 06/2018
2	Reperfusion Injury 01/2017 - 01/2015
2	Inflammation (Inflammations) 01/2017 - 01/2015
1	Fabry Disease (Fabry's Disease) 08/2023
1	Obesity 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Chronic Disease (Chronic Diseases) 01/2023
1	Neoplasms (Cancer) 01/2022
1	Tyrosinemias (Tyrosinemia) 06/2021
1	Hypercholesterolemia 06/2021
1	Liver Diseases (Liver Disease) 06/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Chest Pain (Chest Pains) 01/2019
1	Heart Diseases (Heart Disease) 01/2019
1	Atherosclerotic Plaque (Atheroma) 11/2018
1	Breast Neoplasms (Breast Cancer) 06/2018

6	LipidsIBA 12/2022 - 01/2018
3	Apolipoproteins E (ApoE)IBA 01/2022 - 11/2018
3	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2015
2	LDL Receptors (LDL Receptor)IBA 01/2022 - 01/2018
2	ApolipoproteinsIBA 01/2022 - 06/2021
1	GalactosidasesIBA 08/2023
1	EnzymesIBA 08/2023
1	Kv1.3 Potassium ChannelIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	LDL Lipoproteins (beta Lipoproteins)IBA 12/2022
1	LDL CholesterolIBA 12/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	fumarylacetoacetase (fumarylacetoacetate hydrolase)IBA 06/2021
1	Troponin IIBA 01/2019
1	Capecitabine (Xeloda)FDA Link 06/2018
1	Vinorelbine (Navelbine)FDA LinkGeneric 06/2018
1	Proprotein Convertase 9IBA 01/2018
1	CholesterolIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015
1	CytokinesIBA 01/2015

2	Therapeutics 01/2023 - 01/2022
1	Injections 01/2023
1	Drug Therapy (Chemotherapy) 01/2022
1	Heterologous Transplantation (Xenotransplantation) 01/2017
1	Transplantation 01/2017
1	Organ Transplantation 01/2015